Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verlinde

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Antimicrobial Agents and Chemotherapy|July 11, 2012
Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnibFrederick S Buckner, Maria Terezinha Bahia, Praveen Kumar Suryadevara, et al.
Plos One|November 15, 2018
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1Kathryn E Stephenson, Michael C Keefer, Catherine A Bunce, et al.
Molecular and Biochemical Parasitology|October 31, 2009
Crystal structure of the aspartyl-tRNA synthetase from Entamoeba histolyticaEthan A Merritt, Tracy L Arakaki, Eric T Larson, et al.
Journal of Molecular Biology|February 6, 2010
Crystal structures of trypanosomal histidyl-tRNA synthetase illuminate differences between eukaryotic and prokaryotic homologsEthan A Merritt, Tracy L Arakaki, J Robert Gillespie, et al.
RSC Medicinal Chemistry|January 22, 2021
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against <i>Trypanosoma brucei</i>Zhongsheng Zhang, Ximena Barros-Álvarez, J Robert Gillespie, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in MiceSayaka Shibata, J Robert Gillespie, Angela M Kelley, et al.
BMC Psychiatry|June 19, 2019
Study design of the Routine Outcome Monitoring for Geriatric Psychiatry & Science (ROM-GPS) project; a cohort study of older patients with affective disorders referred for specialised geriatric mental health careRichard C Oude Voshaar, Ton D F Dhondt, Mario Fluiter, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|May 10, 2006
Structure of ribose 5-phosphate isomerase from Plasmodium falciparumMargaret A Holmes, Frederick S Buckner, Wesley C Van Voorhis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2016
Assessment of Anti-HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different PopulationsPhilip J Bergin, Robert Langat, Gloria Omosa-Manyonyi, et al.
ACS Medicinal Chemistry Letters|December 1, 2010
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondiiRyan C Murphy, Kayode K Ojo, Eric T Larson, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Antimicrobial Agents and Chemotherapy|July 11, 2012
Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnibFrederick S Buckner, Maria Terezinha Bahia, Praveen Kumar Suryadevara, et al.
Plos One|November 15, 2018
First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1Kathryn E Stephenson, Michael C Keefer, Catherine A Bunce, et al.
Molecular and Biochemical Parasitology|October 31, 2009
Crystal structure of the aspartyl-tRNA synthetase from Entamoeba histolyticaEthan A Merritt, Tracy L Arakaki, Eric T Larson, et al.
Journal of Molecular Biology|February 6, 2010
Crystal structures of trypanosomal histidyl-tRNA synthetase illuminate differences between eukaryotic and prokaryotic homologsEthan A Merritt, Tracy L Arakaki, J Robert Gillespie, et al.
RSC Medicinal Chemistry|January 22, 2021
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against <i>Trypanosoma brucei</i>Zhongsheng Zhang, Ximena Barros-Álvarez, J Robert Gillespie, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in MiceSayaka Shibata, J Robert Gillespie, Angela M Kelley, et al.
BMC Psychiatry|June 19, 2019
Study design of the Routine Outcome Monitoring for Geriatric Psychiatry & Science (ROM-GPS) project; a cohort study of older patients with affective disorders referred for specialised geriatric mental health careRichard C Oude Voshaar, Ton D F Dhondt, Mario Fluiter, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|May 10, 2006
Structure of ribose 5-phosphate isomerase from Plasmodium falciparumMargaret A Holmes, Frederick S Buckner, Wesley C Van Voorhis, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 1, 2016
Assessment of Anti-HIV-1 Antibodies in Oral and Nasal Compartments of Volunteers From 3 Different PopulationsPhilip J Bergin, Robert Langat, Gloria Omosa-Manyonyi, et al.
ACS Medicinal Chemistry Letters|December 1, 2010
Discovery of Potent and Selective Inhibitors of Calcium-Dependent Protein Kinase 1 (CDPK1) from C. parvum and T. gondiiRyan C Murphy, Kayode K Ojo, Eric T Larson, et al.
Pageof 23